The regulated precursor to the Swiss THC market.
The federal pilot programmes under Art. 8a BetmG form the regulatory precursor to a controlled THC market in Switzerland. Heimat is positioned as a supplier and scientific partner.

Controlled dispensing in several cities.
Regulatory framework
Art. 8a BetmG enables nationally coordinated pilot programmes with controlled dispensing, scientific support and strict evaluation.
Scientific oversight
Every pilot programme is linked to accompanying research. The evidence base is continuously evolving: robust data exist for individual questions, while others remain the subject of ongoing research.
Supplier, partner, data provider.
Product supplier
GMP-compliant THC products with batch traceability, defined active ingredient concentration and complete documentation.
Scientific partner
Contribution to study protocol, accompanying research and real-world evidence collection.
Logistics & compliance
Narcotics-compliant storage, distribution and dispensing documentation.
Regulatory lead time
Data base and experience from the pilot as a basis for future market authorisation.
Partner in the state cannabis pilot programme CAN-Biel.
Standardised THC products
Provision of standardised THC products with defined active ingredient concentration, documented quality and complete batch traceability. The formulations are developed with a focus on standardisation, tolerability and reproducible product quality.
Project partnership WIIID GmbH
Heimat is an official project partner of WIIID GmbH in the Swiss pilot programme, supporting its implementation with expertise in regulatory processes, operational excellence and market infrastructure.
Quality & compliance
Complete documentation across the entire supply chain, from manufacturing to controlled dispensing, in line with the pilot programme's regulatory requirements.
Access to data and experience
Participation in the pilot programme provides access to scientifically collected data, regulatory experience and operational insights for the future development of regulated cannabis markets.
Basis for the next generation of cannabis supply.
Basis
CAN-Biel provides important insights for the future design of a regulated cannabis market in Switzerland.
Building competencies
Through this participation, Heimat builds early competencies in product quality, compliance, traceability and regulated distribution.
Infrastructure for the healthcare channel
Heimat develops the infrastructural prerequisites for collaboration with pharmacies, medical professionals and clinical institutions: from standardised documentation through regulatory requirements to scalable supply structures.
Learn more about the pilot programme.
Speak with our team about the regulatory requirements, the scientific oversight and Heimat's role as supplier and partner.
Let's talk aboutCollaboration.
Whether market access, manufacturing, white label, technology or strategic partnership: speak with our team about joint projects in regulated markets.
